Amyotrophic lateral sclerosis (ALS) is the most common form of degenerative motor neuron disease in adulthood,
1 with an estimated incidence between 1 and 2 cases per 100 000 persons per year.
2,3 The incidence of ALS rises with increasing age, particularly among men, with a mean age at onset of approximately 55 to 58 years.
4,5 The disease is typically rapidly progressive and ultimately fatal, with a median survival of approximately 2 to 4 years after onset.
1